References
- Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991;13:1163–1169. doi:10.1093/clinids/13.6.1163
- Rehman T, Ali J, Lopez FA. A 61-year-old man with asymptomatic, bilateral lung masses. J La State Med Soc. 2008;160:309–14; quiz 349.
- Hirai F, Matsui T, Ishibashi Y, et al. Asymptomatic pulmonary cryptococcosis in a patient with Crohn’s disease on infliximab: case report. Inflamm Bowel Dis. 2011;17:1637–1638. doi:10.1002/ibd.21564
- Hussein M, Haq IU, Hameed M, et al. Isolated pulmonary cryptococcosis in a patient with Crohn’s disease treated with infliximab: a case report and literature review. Respir Med Case Rep. 2021;33:101459. doi:10.1016/j.rmcr.2021.101459
- Osawa R, Singh N. Colitis as a manifestation of infliximab-associated disseminated cryptococcosis. Int J Infect Dis. 2010;14:e436–e440. doi:10.1016/j.ijid.2009.05.019
- Takazono T, Izumikawa K, Yoshioka S, et al. Possible pulmonary cryptococcosis in a patient with Crohn’s disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review. Jpn J Infect Dis. 2012;65:461–464. doi:10.7883/yoken.65.461